All Releases
 |
Myriad Genetics to Present at the UBS Global Life Sciences Conference and the Fifth Annual JMP Securities Healthcare Conference
Aug 31, 2010
|
13.9 KB |
|
| |
SALT LAKE CITY, Aug 31, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark C. Capone, President of Myriad Genetic Laboratories, Inc., is scheduled to present at the UBS Global Life Sciences Conference, at 1:30 p.m. Eastern on September 21, 2010, at the Grand Hyatt Hotel in New York City, an...
|
|
Myriad Announces Additional Stock Repurchase Program
Aug 31, 2010
|
14.5 KB |
|
| |
SALT LAKE CITY, Aug 31, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that its Board of Directors has authorized the repurchase of an additional $100 million of the Company's outstanding common stock, following the completion of its previously authorized stock repurchase program initiated in May...
|
|
Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference and the Stifel Nicolaus Healthcare Conference
Aug 24, 2010
|
13.3 KB |
|
| |
SALT LAKE CITY, Aug 24, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the Morgan Stanley Global Healthcare Conference, at 9:45 a.m. Eastern on September 14, 2010, at the Grand Hyatt Hotel in New York City and the Stifel Nicolau...
|
|
Myriad Genetics Reports Fiscal 2010 Financial Results
Aug 10, 2010
|
21.6 KB |
|
| |
SALT LAKE CITY, Aug 10, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today reported financial results for its fourth quarter and fiscal year ended June 30, 2010.
Financial Results -- Fiscal Fourth Quarter 2010
Revenues increased 9% to $93.9 million in the fourth quarter of fiscal 2010, from $86.1 milli...
|
|
Myriad Genetics Establishes Charitable Program to Give Back to Salt Lake Community
Aug 3, 2010
|
13.9 KB |
|
| |
SALT LAKE CITY, Aug 3, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it has established a Charitable Giving Program. The Program aims to enrich the lives of people living along the Wasatch Front in Utah by supporting and fostering local cultural and arts organizations, as well as help the n...
|
|
Myriad Genetics to Report Fiscal 2010 Fourth Quarter and Year-End Financial Results on August 10
Jul 20, 2010
|
12.3 KB |
|
| |
SALT LAKE CITY, Jul 20, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2010 fourth quarter and year-end financial results at the close of market on Tuesday, August 10, 2010.
The Company will host a conference call on Tuesday, August 10, at 4:30 p.m. Eastern to ...
|
|
Myriad Genetics Announces New Executive Vice President of International Operations
Jul 8, 2010
|
14.8 KB |
|
| |
SALT LAKE CITY, Jul 8, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Gary A. King has joined the Company in the newly created position of Executive Vice President of International Operations.
"It is with a great deal of pleasure that I welcome Gary to the Myriad team," said Peter D. Mel...
|
|
Myriad Genetics Elects Former Roche Molecular Systems CEO Heiner Dreismann to Its Board of Directors
Jun 10, 2010
|
14.3 KB |
|
| |
SALT LAKE CITY, Jun 10, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it has elected Heiner Dreismann, Ph.D. to its Board of Directors, effective immediately, increasing the size of the Company's board from seven members to eight.
"I am extremely pleased to welcome Heiner as our newest ...
|
|
Myriad Genetics to Present at the Goldman Sachs 31st Annual Global Healthcare Conference
Jun 1, 2010
|
12.9 KB |
|
| |
SALT LAKE CITY, Jun 1, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the Goldman Sachs 31st Annual Global Healthcare Conference, at 3:40 p.m. Pacific on June 15, 2010, at the Hyatt Regency Century Plaza Hotel in Los Angeles, Ca...
|
|
Myriad Genetics to Present at the William Blair & Company 30th Annual Growth Stock Conference
Jun 1, 2010
|
12.9 KB |
|
| |
SALT LAKE CITY, Jun 1, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark C. Capone, President of Myriad Genetic Laboratories, Inc., is scheduled to present at the William Blair & Company 30th Annual Growth Stock Conference, at 11:30 a.m. Central on June 15, 2010, at the Four Seasons Hotel ...
|
|
Myriad Genetics to Present at the GARP Research and Securities Company Investor Conference
May 26, 2010
|
12.9 KB |
|
| |
SALT LAKE CITY, May 26, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present at the GARP Research and Securities Company Investor Conference, at 9:30 a.m. Eastern on June 9, 2010, at the Marriott Waterfront Hotel in Baltimore, Maryland. ...
|
|
Myriad Genetics to Present at the Citi 2010 Global Health Care Conference
May 13, 2010
|
13.2 KB |
|
| |
SALT LAKE CITY, May 13, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark C. Capone, President of Myriad Genetic Laboratories, Inc., is scheduled to present at the Citi 2010 Global Health Care Conference, at 10:30 a.m. Eastern on May 27, 2010, at the Hilton New York in New York City.
T...
|
|
Myriad Genetics Reports Financial Results for Fiscal 2010 Third Quarter
May 4, 2010
|
21.6 KB |
|
| |
SALT LAKE CITY, May 4, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today reported financial results for the third fiscal quarter and the nine-month period ended March 31, 2010.
Third Fiscal Quarter Financial Results
Revenues rose 5% to $90.8 million for the three-month period ended March 31, 2010, fro...
|
|
Myriad Announces Stock Repurchase Program
May 4, 2010
|
14.2 KB |
|
| |
SALT LAKE CITY, May 4, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that its Board of Directors has authorized the repurchase of $100 million of the Company's outstanding common stock.
In connection with this stock repurchase authorization, the Company plans to repurchase $100 million of sh...
|
|
Myriad Genetics to Present at the Ninth Annual JMP Securities Research Conference
Apr 28, 2010
|
12.9 KB |
|
| |
SALT LAKE CITY, Apr 28, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Mark C. Capone, President of Myriad Genetic Laboratories, Inc., is scheduled to present at the Ninth Annual JMP Securities Research Conference, at 12:30 p.m. Pacific on May 12, 2010, at the Ritz-Carlton Hotel in San Franc...
|
|
Myriad Genetics Announces New, Convenient OnDose(TM) Sampling Kit
Apr 27, 2010
|
15.9 KB |
|
| |
SALT LAKE CITY, Apr 27, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample...
|
|
Myriad Study Shows PTEN Gene is Useful in Predicting Prostate Cancer Recurrence
Apr 19, 2010
|
15.4 KB |
|
| |
SALT LAKE CITY, Apr 19, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today said results from a recent study indicate that expression of the PTEN gene may be clinically useful in assessing a man's risk of prostate cancer recurrence after radical prostatectomy.
The PTEN gene is one of the most important tumo...
|
|
Myriad Genetics to Report Fiscal 2010 Third Quarter Financial Results On May 4
Apr 13, 2010
|
12.2 KB |
|
| |
SALT LAKE CITY, Apr 13, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2010 third quarter financial results at the close of market on Tuesday, May 4, 2010.
The Company will host a conference call on Tuesday, May 4, at 4:30 p.m. Eastern to review the financial r...
|
|
Federal District Court Rules Isolated DNA Claims are Not Patentable
Mar 30, 2010
|
15.5 KB |
|
| |
SALT LAKE CITY, Mar 30, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis(R) are invalid. Myriad w...
|
|
Novel Gene Expression Test, PROLARIS(TM), Accurately Predicts Prostate Cancer Recurrence
Mar 8, 2010
|
16.1 KB |
|
| |
SALT LAKE CITY, Mar 8, 2010 (GlobeNewswire via COMTEX News Network) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today said data that provides further clinical validation supporting its newest molecular diagnostic product, PROLARIS(TM), was recently presented at the 2010 Genitourinary Cancers Symposium in San Francisco. The abstract of the presentation e...
|
|
|
0.12
